Renowned Speakers
BARRY A. BUNIN
Collaborative Drug Discovery USA
Maia Merlani
Tbilisi State Medical University Georgia
Ahmed M. Radwan
PIONEERA HealthCare Group UK
Sena Caglar Andac
Istanbul University Turkey
Nicola Pugno
Professor University of Trento Italy
Bhanu P S Chauhan
William Paterson University USA
John A. Soderquist
Professor University of Puerto Rico USA
Mark Lautens
University of Toronto Canada
Recommended Global Medical Webinars & Conferences
Asia Pacific & Middle East
Clinical Chemistry 2026
Welcome Message
On behalf of the Organizing Committee, it is our great pleasure to warmly welcome all keynote speakers, invited speakers, delegates, laboratory professionals, participants, exhibitors, and sponsors to the 18th International Conference on Clinical Chemistry, to be held on May 25–26, 2026, in Zurich, Switzerland.
We are truly honored by your presence and participation in this prestigious international gathering. Your expertise, commitment, and support play a vital role in making this conference a platform for scientific excellence and meaningful collaboration.
The theme of this year’s conference, “Clinical Chemistry at the Forefront of Early Disease Detection,” highlights the critical role of clinical chemistry in advancing early diagnosis, improving patient outcomes, and shaping the future of healthcare. Through keynote lectures, scientific sessions, poster presentations, exhibitions, and networking opportunities, this conference aims to foster knowledge exchange and inspire innovation across academia, clinical laboratories, and industry.
We extend our sincere appreciation to our keynote and invited speakers for sharing their insights, to our delegates and laboratory professionals for their active engagement, to our exhibitors for showcasing the latest technologies, and to our sponsors for their generous support in making this event possible.
We wish you a productive, enriching, and memorable experience in Zurich and hope this conference encourages lasting collaborations and advancements in clinical chemistry.
Welcome to the conference, and thank you for being part of this important scientific journey.
About Clinical Chemistry 2026
The 18th International Conference on Clinical Chemistry (Clinical Chemistry 2026) will be held on May 25–26, 2026, in Zurich, Switzerland, bringing together global experts, researchers, clinicians, laboratory professionals, and industry leaders to explore the latest advances in clinical chemistry and laboratory medicine.
Under the theme “Clinical Chemistry at the Forefront of Early Disease Detection,” the conference highlights the pivotal role of clinical chemistry in improving diagnostic accuracy, enabling early diagnosis, and supporting personalized and preventive healthcare. As laboratory medicine continues to evolve rapidly, this meeting serves as a vital platform to discuss emerging technologies, novel biomarkers, automation, quality assurance, and translational research that directly impact patient care.
Clinical Chemistry 2026 will feature keynote and plenary lectures, scientific sessions, oral and poster presentations, panel discussions, and industry exhibitions, providing participants with opportunities to share knowledge, present research findings, and engage in meaningful interdisciplinary dialogue. The conference also aims to foster collaboration between academia, clinical laboratories, healthcare institutions, and industry partners.
Set in the vibrant city of Zurich, the conference offers an inspiring environment for learning, networking, and professional growth. Clinical Chemistry 2026 aspires to advance scientific excellence, encourage innovation, and strengthen global efforts toward earlier disease detection and improved health outcomes.
Why Attend Clinical Chemistry 2026?
Attending the 18th International Conference on Clinical Chemistry (Clinical Chemistry 2026) offers a unique opportunity to stay at the forefront of advances in clinical chemistry and laboratory medicine.
By attending, you will be able to:
- Learn from renowned keynote and invited speakers sharing the latest research and clinical applications
- Gain insights into early disease detection, novel biomarkers, and precision diagnostics
- Explore cutting-edge technologies, instruments, and solutions showcased by leading exhibitors
- Engage in scientific sessions, panel discussions, and poster presentations
- Network with international researchers, clinicians, laboratory professionals, and industry experts
- Exchange ideas, build collaborations, and expand your professional connections
- Enhance your knowledge and skills to improve clinical decision-making and patient outcomes
Clinical Chemistry 2026 provides a dynamic platform for education, innovation, and collaboration in a global setting. Whether you are a researcher, clinician, laboratory professional, student, or industry representative, this conference offers valuable learning and networking opportunities.
Join us in Zurich, Switzerland, on May 25–26, 2026, and be part of shaping the future of clinical chemistry.
Target Audience
The 18th International Conference on Clinical Chemistry (Clinical Chemistry 2026) is designed for a broad spectrum of professionals involved in clinical chemistry, laboratory medicine, and related healthcare and life science fields, including:
- Clinical Chemists
- Laboratory Medicine Professionals and Technologists
- Pathologists
- Clinicians and Physicians
- Biomedical Scientists and Researchers
- Academicians and Educators
- Diagnostic and Healthcare Professionals
- Laboratory Managers and Quality Assurance Specialists
- Industry Experts and Product Developers
- Biotechnology and Pharmaceutical Professionals
- Regulatory and Accreditation Professionals
- Postdoctoral Researchers, Graduate Students, and Early-Career Scientists
- Healthcare Decision-Makers and Policy Professionals
This conference provides an ideal platform for knowledge exchange, professional development, and collaboration among academia, clinical laboratories, healthcare institutions, and industry.
Sessions and Tracks
Session 01: Advances in Clinical Chemistry for Early Disease Detection
Advances in clinical chemistry continue to redefine the way diseases are identified, monitored, and managed at their earliest stages, playing a critical role in modern healthcare and preventive medicine. This session focuses on cutting-edge developments in diagnostic biomarkers, high-sensitivity and high-throughput assays, and innovative analytical methodologies that enhance the early detection of a wide range of diseases, including cardiovascular, metabolic, oncological, infectious, and autoimmune disorders. It emphasizes the growing importance of laboratory automation, digital health solutions, and artificial intelligence-driven data interpretation in improving diagnostic precision, turnaround time, and clinical decision support. The session also addresses the challenges of assay validation, quality control, and standardization across laboratories to ensure reliable and reproducible test results. By highlighting translational research and real-world clinical applications, this session underscores the essential contribution of clinical chemistry in enabling timely diagnosis, personalized treatment strategies, and improved patient outcomes in an evolving healthcare landscape.
Session 02: Innovations in Biomarkers and Molecular Diagnostics
Innovations in biomarkers and molecular diagnostics are revolutionizing disease diagnosis, prognosis, and therapeutic monitoring by enabling highly sensitive and specific detection at the molecular level. This session focuses on the discovery, validation, and clinical application of novel biomarkers, including genomic, proteomic, metabolomic, and epigenetic markers, that support early disease detection and precision medicine. It highlights advances in molecular techniques such as PCR-based assays, next-generation sequencing, and multiplex platforms that are increasingly integrated into clinical chemistry laboratories. The session also addresses challenges related to biomarker standardization, clinical utility, and regulatory approval, while showcasing translational research and real-world applications that bridge laboratory innovation with patient care. By exploring emerging trends and future directions, this session underscores the growing impact of molecular diagnostics in improving diagnostic accuracy, guiding targeted therapies, and advancing personalized healthcare.
Session 03: Role of Clinical Chemistry in Cardiometabolic Disorders
Cardiometabolic disorders, including cardiovascular disease, diabetes, and metabolic syndrome, remain leading causes of morbidity and mortality worldwide, making early detection and monitoring crucial. This session focuses on the role of clinical chemistry in identifying risk factors, monitoring disease progression, and guiding therapeutic interventions for cardiometabolic conditions. It explores advanced biomarkers such as high-sensitivity troponins, natriuretic peptides, lipid subfractions, glycated proteins, and inflammatory markers that improve risk assessment and enable early intervention. The session also highlights the integration of point-of-care testing, laboratory automation, and data analytics in managing cardiometabolic health, emphasizing how precision diagnostics can enhance patient outcomes. Additionally, speakers will discuss challenges in assay standardization, clinical interpretation, and translational implementation to ensure reliable, actionable results in diverse clinical settings. By bridging laboratory research with clinical practice, this session provides participants with insights into innovative strategies for prevention, early detection, and personalized management of cardiometabolic disorders.
Session 04: Emerging Technologies and Automation in Clinical Laboratories
Rapid technological advancements are transforming clinical laboratories, making them faster, more accurate, and increasingly integrated with digital health systems. This session focuses on emerging technologies and automation in clinical chemistry, highlighting innovations such as fully automated analyzers, robotic sample handling, microfluidic platforms, and high-throughput screening systems. The integration of artificial intelligence, machine learning, and big data analytics in laboratory workflows is also emphasized, demonstrating how these tools enhance result interpretation, predictive diagnostics, and laboratory efficiency. Participants will explore the impact of these technologies on quality control, standardization, and regulatory compliance, as well as their role in reducing human error and turnaround times. Case studies will showcase real-world applications where automation and advanced technologies have improved laboratory productivity and patient care. By bridging technological innovation with practical laboratory implementation, this session provides insights into the future of clinical chemistry laboratories and their evolving role in early disease detection and precision medicine.
Session 05: Clinical Chemistry in Oncology and Early Cancer Detection
Early detection and monitoring of cancer remain critical challenges in improving patient survival and treatment outcomes, and clinical chemistry plays an increasingly important role in addressing these challenges. This session focuses on the use of novel biomarkers, including protein markers, circulating tumor DNA (ctDNA), microRNAs, and metabolomic profiles, to detect cancer at its earliest stages and monitor treatment response. Advances in high-sensitivity assays, multiplex testing, and liquid biopsy technologies will be highlighted, demonstrating how clinical laboratories are moving toward less invasive, more accurate, and timely diagnostic solutions. The session will also explore the integration of molecular diagnostics, artificial intelligence, and bioinformatics in identifying predictive and prognostic markers, supporting personalized therapy decisions, and enhancing risk stratification. Challenges such as assay standardization, clinical validation, and implementation in routine practice will be discussed, along with translational research bridging laboratory discoveries with patient care. Participants will gain insights into how clinical chemistry is transforming oncology diagnostics, enabling early intervention, improved therapeutic monitoring, and better overall patient outcomes.
Session 06: Clinical Chemistry in Infectious Diseases and Pandemic Preparedness
The detection, monitoring, and management of infectious diseases have become increasingly critical in safeguarding global health, particularly in the context of emerging pathogens and pandemics. This session focuses on the pivotal role of clinical chemistry in diagnosing bacterial, viral, and parasitic infections, as well as in monitoring immune responses and treatment efficacy. Advances in rapid diagnostic assays, point-of-care testing, molecular techniques, and biomarker-based approaches will be highlighted, demonstrating how timely and accurate laboratory results guide clinical decision-making and public health interventions. The session will also explore the integration of automation, data analytics, and digital reporting systems to enhance laboratory efficiency, surveillance, and outbreak response. Challenges related to assay sensitivity, specificity, standardization, and implementation in resource-limited settings will be addressed, along with strategies for improving preparedness and resilience against infectious threats. Participants will gain insights into how clinical chemistry laboratories contribute to early detection, disease monitoring, and effective pandemic response, emphasizing their central role in protecting individual and population health.
Session 07: Clinical Chemistry in Pediatric and Neonatal Care
Pediatric and neonatal populations present unique challenges in disease detection, diagnosis, and monitoring, requiring specialized approaches in clinical chemistry. This session focuses on the application of advanced laboratory techniques and biomarkers to identify metabolic disorders, congenital conditions, infections, and nutritional deficiencies in newborns and children. High-sensitivity assays, point-of-care testing, and age-specific reference ranges are emphasized as critical tools for accurate diagnosis and early intervention. The session also explores the use of automated platforms and multiplex testing to streamline workflows in neonatal screening programs and pediatric laboratories, ensuring timely and reliable results. Additionally, speakers will discuss translational research that bridges laboratory discoveries with clinical care, as well as strategies for improving standardization, quality assurance, and interpretation of results in pediatric populations. Participants will gain a comprehensive understanding of how clinical chemistry supports early detection, treatment planning, and long-term monitoring in children, ultimately contributing to improved health outcomes from the earliest stages of life.
Session 08: Quality Management, Standardization, and Regulatory Compliance
Reliable and accurate laboratory results are the cornerstone of effective clinical decision-making, making quality management, standardization, and regulatory compliance essential in clinical chemistry. This session focuses on best practices for ensuring analytical accuracy, reproducibility, and consistency across laboratories, covering topics such as method validation, internal and external quality control, and proficiency testing. Participants will explore international standards, accreditation requirements, and regulatory frameworks that guide laboratory operations and ensure patient safety. The session also highlights strategies for harmonizing assays, implementing standard operating procedures, and addressing pre-analytical, analytical, and post-analytical challenges in diverse clinical settings. Additionally, the role of laboratory information systems, automation, and data management in supporting quality assurance and regulatory compliance will be discussed. By emphasizing the integration of quality management systems with modern diagnostic technologies, this session provides participants with practical insights into maintaining excellence in laboratory practice, supporting reliable early disease detection, and meeting global standards in clinical chemistry.
Session 09: Personalized Medicine and Precision Diagnostics
The shift toward personalized medicine has transformed the role of clinical chemistry, enabling tailored diagnostic and therapeutic strategies based on individual patient profiles. This session focuses on the application of precision diagnostics, biomarker-guided testing, and advanced laboratory technologies to support individualized patient care. Topics include pharmacogenomics, risk stratification, predictive biomarkers, and integration of multi-omics data to guide treatment decisions and monitor therapeutic efficacy. The session also explores how artificial intelligence, machine learning, and big data analytics are being used to interpret complex laboratory results, identify patterns, and enhance clinical decision-making. Challenges such as clinical validation, assay standardization, ethical considerations, and implementation in routine practice will be addressed. By bridging laboratory innovation with patient-centered care, this session provides participants with insights into how clinical chemistry is advancing personalized medicine, improving diagnostic accuracy, and optimizing outcomes through more targeted, precise, and proactive healthcare approaches.
Session 10: Emerging Trends and Future Directions in Clinical Chemistry
As clinical chemistry continues to evolve, emerging trends and innovations are shaping the future of diagnostics, laboratory medicine, and early disease detection. This session explores cutting-edge developments such as multi-omics approaches, novel biomarker discovery, high-throughput and point-of-care technologies, and the integration of artificial intelligence and machine learning in laboratory workflows. The session also addresses the growing importance of digital health, telemedicine, and data-driven decision support in transforming patient care and laboratory operations. Participants will gain insights into upcoming challenges and opportunities, including assay standardization, regulatory adaptation, and the translation of research discoveries into clinical practice. Additionally, real-world case studies will highlight successful implementation of innovative diagnostic strategies, demonstrating their impact on early detection, personalized medicine, and public health. By examining these emerging trends, this session provides a forward-looking perspective on how clinical chemistry will continue to advance healthcare, improve patient outcomes, and shape the next generation of laboratory science.
Session 11: Role of Clinical Chemistry in Neurodegenerative and Neurological Disorders
Neurodegenerative and neurological disorders, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis, present significant diagnostic challenges due to their complex pathophysiology and often subtle early symptoms. This session focuses on the role of clinical chemistry in the early detection, monitoring, and management of neurological conditions through the use of advanced biomarkers, neurochemical assays, and molecular diagnostic techniques. Topics include cerebrospinal fluid analysis, blood-based biomarkers, neuroimaging correlates, and the integration of multi-omics approaches for improved disease characterization. The session also highlights how automation, high-sensitivity assays, and digital tools support reliable laboratory measurements and longitudinal patient monitoring. Additionally, participants will explore translational research that bridges laboratory discoveries with clinical application, addressing challenges in standardization, assay validation, and interpretation of complex neurological data. By emphasizing innovative diagnostic strategies and personalized approaches, this session provides insights into how clinical chemistry contributes to early diagnosis, treatment planning, and improved patient outcomes in neurodegenerative and neurological disorders.
Session 15: Clinical Chemistry in Emergency and Critical Care
Timely and accurate laboratory testing is crucial in emergency and critical care settings, where rapid decision-making can significantly impact patient outcomes. This session focuses on the role of clinical chemistry in acute care, including the assessment of cardiac events, sepsis, respiratory failure, electrolyte imbalances, and multi-organ dysfunction. Topics include the use of high-sensitivity biomarkers, point-of-care testing, rapid assays, and automated analyzers to support immediate diagnosis and monitoring in critically ill patients. The session also explores the integration of laboratory data with clinical decision support systems, predictive analytics, and digital health technologies to improve triage, treatment planning, and patient management. Challenges such as pre-analytical variability, assay standardization, and interpretation under urgent conditions are addressed. By highlighting real-world case studies and translational applications, this session demonstrates how clinical chemistry enhances timely intervention, optimizes patient care, and improves outcomes in emergency and critical care environments.
Session 16: Clinical Chemistry in Endocrinology and Metabolic Disorders
Endocrine and metabolic disorders, including diabetes, thyroid dysfunction, adrenal disorders, and lipid abnormalities, require precise and timely laboratory assessment for effective diagnosis, monitoring, and management. This session focuses on the role of clinical chemistry in evaluating hormonal imbalances, metabolic biomarkers, and related biochemical parameters using advanced assays and automated laboratory platforms. Topics include high-sensitivity tests, point-of-care devices, and multiplex technologies that enable early detection, risk stratification, and monitoring of treatment efficacy. The session also addresses challenges such as assay standardization, reference range variability, and integration of laboratory results with clinical data for personalized patient management. Additionally, emerging trends in metabolomics, molecular diagnostics, and data-driven approaches in endocrine and metabolic health are highlighted. By bridging laboratory innovation with clinical practice, this session demonstrates how clinical chemistry supports early diagnosis, precision treatment, and improved outcomes for patients with endocrine and metabolic disorders.
Session 17: Clinical Chemistry in Nutritional Assessment and Metabolic Health
Nutritional status and metabolic health are fundamental determinants of overall well-being, and clinical chemistry plays a key role in their assessment, monitoring, and management. This session focuses on the use of biochemical markers, including vitamins, minerals, trace elements, protein levels, and lipid profiles, to evaluate nutritional deficiencies, metabolic imbalances, and diet-related disorders. It highlights advanced analytical techniques, high-throughput assays, and point-of-care testing that enable accurate and timely assessment of nutritional status in diverse populations. The session also explores the integration of laboratory data with clinical evaluations, personalized nutrition strategies, and predictive analytics to guide preventive and therapeutic interventions. Challenges such as assay standardization, variability in reference ranges, and interpretation in special populations such as children, pregnant women, and the elderly—are addressed. By emphasizing translational research, innovative diagnostics, and practical applications, this session demonstrates how clinical chemistry supports optimal metabolic health, early detection of nutrition-related disorders, and improved patient care.
Session 18: Clinical Chemistry in Therapeutic Drug Monitoring and Pharmacology
Therapeutic drug monitoring (TDM) is essential for optimizing drug efficacy, minimizing toxicity, and ensuring personalized treatment, particularly for medications with narrow therapeutic windows or variable patient responses. This session focuses on the application of clinical chemistry in measuring drug concentrations, assessing pharmacokinetics, and monitoring treatment compliance across a wide range of therapeutic agents, including antibiotics, immunosuppressants, antiepileptics, and oncology drugs. Advanced analytical techniques, such as high-performance liquid chromatography (HPLC), mass spectrometry, and automated immunoassays, are highlighted for their accuracy, sensitivity, and reliability. The session also explores integration of TDM with pharmacogenomics, data analytics, and clinical decision support systems to guide individualized therapy and improve patient outcomes. Challenges such as assay standardization, drug interactions, and interpretation of results in complex clinical scenarios are addressed. By emphasizing translational research and real-world applications, this session demonstrates how clinical chemistry enhances personalized pharmacotherapy, supports safe and effective drug use, and contributes to improved patient care.
Session 19: Clinical Chemistry in Infectious Disease Surveillance and Public Health
Clinical chemistry plays a critical role not only in individual patient care but also in public health by supporting infectious disease surveillance, outbreak detection, and population-level monitoring. This session focuses on the application of laboratory diagnostics, biomarkers, and molecular testing in tracking bacterial, viral, and parasitic infections, including emerging and re-emerging pathogens. It highlights rapid diagnostic assays, high-throughput platforms, and point-of-care technologies that enable timely detection, reporting, and response to infectious threats. The session also explores the integration of laboratory data with epidemiological models, digital health systems, and predictive analytics to inform public health strategies, guide vaccination campaigns, and support containment measures during outbreaks and pandemics. Challenges such as assay sensitivity, specificity, standardization, and implementation in resource-limited settings are addressed. By showcasing translational research, real-world case studies, and innovative approaches, this session demonstrates how clinical chemistry contributes to early detection, effective monitoring, and evidence-based public health interventions, ultimately enhancing global health security.
Session 20: Clinical Chemistry in Artificial Intelligence and Digital Health
The integration of artificial intelligence (AI), machine learning, and digital health technologies is transforming clinical chemistry by enabling faster, more accurate, and data-driven diagnostic decisions. This session focuses on how AI-powered algorithms, predictive modeling, and advanced data analytics are being applied to laboratory data for early disease detection, risk stratification, and personalized patient management. Topics include automated result interpretation, pattern recognition in multi-omics datasets, predictive biomarker discovery, and integration with electronic health records for comprehensive clinical insights. The session also addresses challenges such as data privacy, algorithm validation, interoperability of digital systems, and standardization of AI applications in clinical laboratories. By showcasing real-world case studies, translational research, and emerging digital tools, this session highlights how clinical chemistry is evolving in the era of digital medicine, enhancing laboratory efficiency, improving diagnostic accuracy, and supporting personalized, proactive healthcare.
Market Analysis Report
The global clinical chemistry market was valued at approximately USD 12.5 billion in 2020, driven by the increasing prevalence of chronic diseases, rising demand for early disease detection, and growing adoption of advanced laboratory technologies. The market growth in 2020 was supported by the expansion of diagnostic laboratories, advancements in automation and high-throughput analyzers, and increased awareness among healthcare providers about the importance of timely and accurate laboratory testing. Additionally, the rising geriatric population and the prevalence of metabolic, cardiovascular, and infectious diseases contributed significantly to market demand during this period.
Looking forward, the clinical chemistry market is projected to reach around USD 21.8 billion by 2030, reflecting strong growth due to technological innovations such as point-of-care testing, multiplex assays, and integration of digital health solutions and artificial intelligence in laboratory workflows. The growing emphasis on personalized medicine, preventive healthcare, and early diagnosis of complex diseases is expected to further fuel market expansion. Emerging markets, particularly in Asia-Pacific and Latin America, are anticipated to witness substantial adoption of clinical chemistry technologies due to increasing healthcare investments and infrastructure development.
Overall, the market is expected to grow at a compound annual growth rate (CAGR) of approximately 5.6% from 2021 to 2030, driven by continuous innovation in assay development, automation, and biomarker discovery. Increased collaborations between diagnostic companies, healthcare institutions, and research organizations are likely to accelerate product launches and enhance market penetration. Furthermore, the growing demand for rapid, accurate, and cost-effective diagnostic solutions across hospitals, clinical laboratories, and point-of-care settings will continue to support sustainable long-term growth of the clinical chemistry market.
- American Association for Clinical Chemistry (AACC)
- International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
- American Society for Clinical Laboratory Science (ASCLS)
- Clinical and Laboratory Standards Institute (CLSI)
- British Clinical Chemistry Society (BCCS)
- Canadian Society of Clinical Chemists (CSCC)
- Asia Pacific Federation for Clinical Biochemistry (APFCB)
- Japanese Society of Clinical Chemistry (JSCC)
- Society for Laboratory Medicine (SLM)
The 18th International Conference on Clinical Chemistry offers participants multiple ways to engage under Academic / Student / Business Categories:
- Keynote Speaker: 45–50 minutes
- Speaker (Oral Presentation): 25–30 minutes (single presenter)
- Speaker (Workshop): 45–50 minutes (multiple presenters allowed)
- Speaker (Special Session): 45–50 minutes (multiple presenters allowed)
- Speaker (Symposium): More than 45 minutes (multiple presenters allowed)
- Delegate (Registration Only): Access to all sessions and benefits of registration
- Poster Presenter: Present a poster and enjoy delegate benefits
- Remote Attendance: Participate via video presentation or e-poster presentation
- Exhibitor: Exhibit your company’s products by booking booths of different sizes
- Media Partner
- Sponsor
- Collaborator
Advantages of Participating at Clinical Chemistry 2026
- Gain global visibility for your speaker and abstract pages under your profile
- Conference library of abstracts receives high monthly traffic, enhancing recognition
- Opportunities to meet and exchange ideas with leading experts in clinical chemistry
- Exceptional chance to hear discoveries from world-renowned keynote speakers
- Engage in one-on-one discussions with distinguished speakers and participants
Benefits of Participation for Speakers
- Gain international recognition for your research profile
- Earn points for professional development
- Discover the latest research and innovations in clinical chemistry
- Network and form lifelong professional connections
- Promote your work through abstract books and conference materials, gaining wide visibility
- Explore topics beyond your primary research focus, expanding knowledge
- Enjoy a combination of networking, education, and engaging activities
Benefits of Participation for Delegates
- Enhance knowledge and understanding for professional and academic growth
- Attend webinars, oral presentations, and workshops to stay informed
- Contribute to the development of new approaches in clinical chemistry
- Connect and share perspectives with scholars, researchers, and practitioners
Benefits of Participation for Sponsors
- Increase exposure to the global clinical chemistry marketplace
- Showcase innovative products, technologies, or services to an international audience
- Generate leads and new business opportunities
- Network with like-minded professionals to support growth
- Gain insights, feedback, and solutions from experts and peers
Submit Your Abstract
Share your research and innovations in clinical chemistry by submitting your abstract here:
[Submit Abstract Link]
Register Now
Secure your spot at the conference and enjoy access to all sessions, networking, and benefits:
[Registration Link]
Past Conference Report
Clinical Chemistry 2025
Welcome to the 17th International Conference on Clinical Chemistry, taking place on May 14-15, 2025, in Toronto, Canada. This year's conference theme is "Transforming Diagnostics: Innovations and Insights in Clinical Chemistry."
This premier event brings together leading professionals, researchers, and industry experts to explore the latest advancements and emerging trends in clinical chemistry. As the field evolves, driven by technological innovations and a deeper understanding of biomolecular mechanisms, this conference provides a crucial platform for discussing transformative approaches and their impact on diagnostic practices.
Past Reports Gallery
To Collaborate Scientific Professionals around the World
Conference Date May 25-26, 2026
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by